[13] Trials for obesity [edit] In March 2021, in a phase III randomized, double-blind trial, 1,961 adults with a body mass index of 30 or greater were assigned in a 2:1 ratio to a treatment with once-weekly subcutaneous semaglutide or placebo, plus lifestyle intervention
Fat positivity challenges traditional metrics like BMI (body mass index) as a measure of health, and promotes advocacy against stigma
If you are not sure where to inject, speak to your doctor for advice
Individuals taking Mounjaro or other GLP-1s should be monitored closely for symptoms of blood clots and deep vein thrombosis
After that, it slows down
You should also check your blood sugar often